Davy Chiodin is an accomplished leader in regulatory affairs and product development, currently serving as Chief Development Officer at Day One Biopharmaceuticals since October 2019. Prior to this role, Davy held several senior positions at Acerta Pharma, including Senior Vice President - Product Development, where responsibility included developing oncology compounds. Davy's earlier experience at Genentech encompassed various roles in regulatory affairs, notably for pediatric oncology and solid tumor portfolios. Davy started a career in regulatory affairs at AstraZeneca as EU/Global Regulatory Affairs Manager. Davy holds a PharmD from Université Grenoble Alpes and master's degrees in Pharma Law & Pharmacoeconomics from the University of Lille 1 Sciences and Technology and in Regulatory Affairs and Pharmacoeconomics from Université René Descartes - Paris V.
Sign up to view 1 direct report
Get started